Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin
NCT ID: NCT05203354
Last Updated: 2022-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2018-09-01
2021-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .
NCT05401006
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis
NCT05427175
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
NCT04811911
Effect Narrow-Band UVB Radiations
NCT05647187
Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy
NCT03483311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NB-UVB group
Patients who receive Narrowband ultraviolet B phototherapy
Narrowband Ultraviolet B
patients will exposed to sessions of NB-UVB phototherapy twice weekly for 3 months
Acitretin group
Patients who receive acitretin
Acitretin
patients will received acitretin in dose 0.5-1 mg/kg daily for 3 months
Control group
It includes apparently healthy people who will be compared to patients in the measurement of Omentin-1 level
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrowband Ultraviolet B
patients will exposed to sessions of NB-UVB phototherapy twice weekly for 3 months
Acitretin
patients will received acitretin in dose 0.5-1 mg/kg daily for 3 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients received NB-UVB phototherapy in the last 6 months.
* Patients treated with methotrexate or biologic agents and any systemic treatment of psoriasis.
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahmoud Ahmed Ali Ahmed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Ahmed Ali Ahmed
Assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine - Aswan university
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
288/9/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.